Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4080447 | Orthopaedics and Trauma | 2010 | 6 Pages |
Abstract
The incidence of renal cell carcinoma (RCC) is increasing. While there has been considerable improvement in the management of early localized disease, that of advanced metastatic disease remains controversial as does the influence of prognostic factors on survival. However there are indicators of improved survival. There is a patient subset with a solitary renal metastasis in whom aggressive surgical management may be curative. Multimodal therapy and extended surgical resection have improved 5-year survival rate.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Shaishav Bhagat, Himanshu Sharma, John Graham, Anthony T. Reece,